Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

XSEC:002675 Stock Report

Market Cap: CN¥10.6b

Yantai Dongcheng Pharmaceutical GroupLtd Balance Sheet Health

Financial Health criteria checks 6/6

Yantai Dongcheng Pharmaceutical GroupLtd has a total shareholder equity of CN¥5.5B and total debt of CN¥839.7M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are CN¥8.6B and CN¥3.2B respectively. Yantai Dongcheng Pharmaceutical GroupLtd's EBIT is CN¥233.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥955.2M.

Key information

15.4%

Debt to equity ratio

CN¥839.75m

Debt

Interest coverage ratio3.2x
CashCN¥955.20m
EquityCN¥5.47b
Total liabilitiesCN¥3.17b
Total assetsCN¥8.64b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 002675's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥1.7B).

Long Term Liabilities: 002675's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥1.5B).


Debt to Equity History and Analysis

Debt Level: 002675 has more cash than its total debt.

Reducing Debt: 002675's debt to equity ratio has reduced from 17.8% to 15.4% over the past 5 years.

Debt Coverage: 002675's debt is well covered by operating cash flow (43.1%).

Interest Coverage: 002675's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balance Sheet


Discover healthy companies